Management of Alcohol Withdrawal Symptoms

Understanding Alcohol Withdrawal Syndrome (AWS)

The American Association for the Study of Liver Diseases notes that AWS typically develops within 6-24 hours after the last drink and can include increased blood pressure, tachycardia, tremors, hyperreflexia, irritability, anxiety, headache, nausea, and vomiting 3, 4
These symptoms can progress to more severe forms including delirium tremens, seizures, coma, and potentially death if not properly managed 3

The European Society of Intensive Care Medicine recommends clonidine as part of benzodiazepine-sparing protocols for managing AWS, as it directly addresses the adrenergic storm associated with AWS by decreasing norepinephrine release, effectively reducing symptoms of sympathetic overdrive including anxiety, agitation, elevated blood pressure, tachycardia, and tremor 1, 2
The American Association for the Study of Liver Diseases suggests that while benzodiazepines are considered the gold standard for AWS treatment, they carry risks of abuse potential and may not be the first choice for a patient with chronic alcohol abuse who is attempting to achieve sobriety 3, 4

The Clinical and Molecular Hepatology society recommends thiamine supplementation (100-300 mg/day) to prevent Wernicke encephalopathy, a common complication of alcohol withdrawal, and notes that thiamine should be administered before any glucose-containing fluids to prevent precipitating acute thiamine deficiency 6

The Journal of Hepatology suggests that after acute withdrawal is managed, consider medications that support long-term abstinence such as baclofen, which has shown efficacy and safety in patients with liver disease 4
The Clinical and Molecular Hepatology society recommends psychiatric consultation for evaluation, treatment, and long-term planning for alcohol abstinence 6